Do Drug Metabolism and Pharmacokinetic Departments Make Any Contribution to Drug Discovery? Dennis SmithEsther SchmidBarry Jones Current Opinion 13 September 2012 Pages: 1005 - 1019
Clinical Pharmacokinetics of Tegaserod, a Serotonin 5-HT4 Receptor Partial Agonist with Promotile Activity Silke Appel-Dingemanse Review Articles 13 September 2012 Pages: 1021 - 1042
Clinical Pharmacokinetics and Pharmacodynamics of Insulin Lispro Mixtures Paris RoachJames R. Woodworth Review Articles 13 September 2012 Pages: 1043 - 1057
Pharmacokinetics and Pharmacodynamics of Rapacuronium Bromide William J. WightPeter M. C. Wright Review Articles 13 September 2012 Pages: 1059 - 1076
Ontogeny of Hepatic and Renal Systemic Clearance Pathways in Infants: Part II Jane AlcornPatrick J. McNamara Review Articles 13 September 2012 Pages: 1077 - 1094
Bayesian Estimation of Methotrexate Pharmacokinetic Parameters and Area Under the Curve in Children and Young Adults with Localised Osteosarcoma Annick RousseauChristophe SabotPierre Marquet Original Research Article 13 September 2012 Pages: 1095 - 1104
Pharmacokinetic-Pharmacodynamic Modelling of Magnesium Plasma Concentration and Blood Pressure in Preeclamptic Women Jianfeng LuMarc PfisterLewis Sheiner Original Research Article 13 September 2012 Pages: 1105 - 1113
